Atlas Trials

Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease

Clinical trial NCT02330510 · COMPLETED

Trial details

NCT number
NCT02330510
Sponsor
Dr. Sandra E Black
Status
COMPLETED
Study type
OBSERVATIONAL
Alzheimer's DiseaseSmall Vessel Disease White Matter Hyperintensities SubtypeVascular Cognitive Impairment
Start date
2014-08-01
Primary completion
2024-12-10
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.